1,666 HCA Healthcare, Inc. $HCA Shares Sold by KG Capital Management

KG Capital Management cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 63.4% during the third quarter, HoldingsChannel.com reports. The fund owned 963 shares of the company’s stock after selling 1,666 shares during the period. KG Capital Management’s holdings in HCA Healthcare were worth $411,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Anchyra Partners LLC lifted its stake in HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock worth $278,000 after purchasing an additional 21 shares in the last quarter. SJS Investment Consulting Inc. boosted its holdings in shares of HCA Healthcare by 73.1% during the 1st quarter. SJS Investment Consulting Inc. now owns 90 shares of the company’s stock worth $43,000 after purchasing an additional 38 shares during the last quarter. EverSource Wealth Advisors LLC grew its position in shares of HCA Healthcare by 4.2% in the first quarter. EverSource Wealth Advisors LLC now owns 935 shares of the company’s stock valued at $442,000 after purchasing an additional 38 shares in the last quarter. Frank Rimerman Advisors LLC increased its holdings in shares of HCA Healthcare by 0.6% in the first quarter. Frank Rimerman Advisors LLC now owns 6,845 shares of the company’s stock valued at $3,239,000 after purchasing an additional 44 shares during the last quarter. Finally, Monument Capital Management increased its stake in shares of HCA Healthcare by 7.0% in the 3rd quarter. Monument Capital Management now owns 672 shares of the company’s stock worth $287,000 after acquiring an additional 44 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 2.1%

Shares of HCA opened at $470.25 on Thursday. The company’s 50-day moving average price is $424.28 and its 200 day moving average price is $419.02. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The firm has a market cap of $101.81 billion, a P/E ratio of 15.51, a price-to-earnings-growth ratio of 1.55 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. During the same period last year, the business earned $6.84 earnings per share. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. Equities research analysts forecast that HCA Healthcare, Inc. will post 29.45 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th were issued a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date was Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.

Analyst Ratings Changes

Several research analysts have recently commented on HCA shares. Weiss Ratings upgraded HCA Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a report on Thursday, October 8th. Oppenheimer dropped their price objective on shares of HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a report on Monday, July 27th. UBS Group cut their price objective on shares of HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a research report on Monday, July 27th. Mizuho reduced their target price on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 28th. Finally, BMO Capital Markets assumed coverage on shares of HCA Healthcare in a research note on Tuesday, September 22nd. They issued an “outperform” rating and a $495.00 price target for the company. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $467.61.

About HCA Healthcare

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women’s and children’s care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.